• Applied Workflows with Recombinant Human EGF: Spheroid Assay

  2026-06-18

  Harnessing recombinant human EGF unlocks advanced, reproducible control over cell proliferation and stemness detection in glioblastoma and regenerative models. This guide translates cutting-edge protocol innovations and troubleshooting strategies into direct experimental advantages, leveraging APExBIO’s high-purity EGF for superior assay performance.

• Bleomycin Sulfate: Mechanistic Insight and Strategic Leverag

  2026-06-17

  Explore how Bleomycin Sulfate (Blenoxane) enables advanced translational research by bridging mechanistic understanding of DNA damage and fibrosis with actionable protocol guidance. This article unpacks recent breakthroughs in mitophagy, highlights APExBIO's product strengths, and delivers a forward-looking perspective for researchers tackling pulmonary fibrosis and oncology models.

• Fluorescein Tyramide in Circuit Mapping: Signal Amplificatio

  2026-06-17

  Explore how Fluorescein Tyramide enables ultra-sensitive neural circuit mapping by achieving robust signal amplification in immunohistochemistry and in situ hybridization. This in-depth article reveals scientific insights, advanced protocols, and practical assay recommendations distinct from prior content.

• Pentoxifylline Modulates Hyperinflammation in Preterm Monocy

  2026-06-16

  This study demonstrates that pentoxifylline (PTX) significantly downregulates LPS-induced inflammatory responses in preterm infant monocytes by targeting TLR4 signaling and cytokine expression. The findings provide mechanistic insight into PTX’s age-dependent immunomodulatory effects and support its ongoing evaluation in neonatal sepsis models.

• Structural Insights into HCAR3 Agonist Recognition and Selec

  2026-06-16

  This study presents high-resolution cryo-EM structures of the hydroxycarboxylic acid receptor 3 (HCAR3) in complex with selective agonists, including Acifran, revealing the molecular determinants of ligand recognition and selectivity. These findings advance our understanding of GPCR-mediated lipid metabolism regulation and inform the rational design of HCAR3-specific hypolipidemic agents.

• Buffer Optimization Stabilizes RNA LNPs for Nebulized Lung D

  2026-06-15

  This study demonstrates that optimizing nebulization buffer composition can significantly stabilize RNA-loaded lipid nanoparticles (LNPs) for inhalable delivery. By fine-tuning buffer pH and excipient selection, the approach preserves nanoparticle size, RNA encapsulation, and bioactivity, addressing a core challenge in pulmonary RNA therapeutics.

• ICG001: Wnt/β-Catenin Pathway Inhibitor in Translational Res

  2026-06-15

  ICG001 empowers researchers to dissect Wnt/β-catenin signaling with precision, enabling advanced modeling of cancer and fibrosis. This comprehensive guide outlines practical workflows, troubleshooting insights, and recent innovation, making ICG001 an essential tool for translational science.

• CDC42 Polarity Regulates Intestinal Stem Cell Fate via YAP-m

  2026-06-14

  Zhang et al. uncover how CDC42-driven epithelial polarity orchestrates the balance between intestinal stem cells and transit amplifying cells through YAP-EGF-mTOR signaling, independently of Wnt pathways. These findings provide a mechanistic basis for epithelial homeostasis and open new avenues for gastrointestinal stem cell research.

• Antiarrhythmic Drugs and KCa2 Channel Modulation in AF Resea

  2026-06-13

  This study systematically evaluates whether established antiarrhythmic agents, including Dronedarone (Multaq), directly inhibit small conductance calcium-activated potassium (KCa2) channels at concentrations relevant for atrial fibrillation (AF) treatment. Findings indicate that most clinically used drugs lack meaningful KCa2 channel inhibition, highlighting the need for new atrial-selective pharmacological strategies.

• Autophagy Modulates Resveratrol-Induced Apoptosis in RCC Cel

  2026-06-12

  This study reveals that autophagy acts as a protective mechanism against resveratrol-induced apoptosis in renal cell carcinoma 786-O cells. By dissecting the roles of mitochondrial dysfunction, reactive oxygen species, and the caspase signaling pathway, the research highlights interplay between cell death and survival pathways, informing future cancer therapy strategies.

• 7-AAD Cell Viability Assay Kit: Precision in Apoptosis Detec

  2026-06-12

  The 7-AAD Cell Viability Assay Kit empowers researchers to accurately distinguish necrotic and late apoptotic cells in multiplexed cytometric workflows. By leveraging insights from CD38 CAR-T structural research, this assay offers unmatched spectral clarity and workflow versatility, making it a critical tool for advanced immunotherapy and cell engineering studies.

• nor-NOHA Acetate: Redefining Arginase Inhibition for Tumor M

  2026-06-11

  Explore how nor-NOHA acetate enables precision modulation of arginine metabolism and immune regulation in cancer research. This article offers new insights by connecting arginase inhibition with immunometabolic pathways and practical assay design.

• FITC-Concanavalin A (ConA) Conjugate: Technical Workflow Gui

  2026-06-11

  FITC-Concanavalin A (ConA) Conjugate enables direct, fluorescence-based detection of α-D-glucose and α-D-mannose residues on cell surfaces, supporting precise workflows in immunofluorescence and flow cytometry. This product is not suitable for non-carbohydrate targets or for use outside its specified storage and stability limits.

• Spiroplasma eriocheiris Entry in Drosophila S2 Cells: Cytosk

  2026-06-10

  This study demonstrates that Spiroplasma eriocheiris enters Drosophila S2 cells primarily via clathrin-mediated endocytosis and macropinocytosis, with infection strictly dependent on both actin and microtubule dynamics. The findings highlight new mechanistic insights into host-pathogen interactions in invertebrate models and inform design of assays targeting cytoskeletal pathways.

• Isradipine (Dynacirc): Advancing Calcium Channel Selectivity

  2026-06-10

  Explore how Isradipine (Dynacirc) sets a new benchmark for selective L-type calcium channel inhibition in neurovascular research. This in-depth analysis reveals the unique scientific considerations, assay decisions, and translational impact of Isradipine, distinguishing its role from traditional pharmacological tools.

15417 records 1/1028 page Next 12345 下5页 Last page